Study comparing two types of screening provision for people with von Hippel-Lindau disease

Author： Fraser Lindsay   Watts Sally   Cargill Anna   Sutton Stephen   Hodgson Shirley  

Publisher： Springer Publishing Company

ISSN： 1389-9600

Source： Familial Cancer, Vol.6, Iss.1, 2007-03, pp. : 103-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hemangioblastomatosis in a patient with von Hippel-Lindau disease

By Hanse M.   Vincent A.   Bent M.  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 163-164

Springer Publishing Company

Access to resources Recommend Favorite

Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1: Review

By Opocher Giuseppe   Conton Pierantonio   Schiavi Francesca   Macino Beatrice   Mantero Franco  

Familial Cancer, Vol. 4, Iss. 1, 2005-03 ,pp. : 13-16

Springer Publishing Company

Access to resources Recommend Favorite

Targeting von Hippel–Lindau syndrome: the future is now

By Matin Surena F   Jonasch Eric  

Future Oncology, Vol. 2, Iss. 3, 2006-06 ,pp. : 321-323

Future Medicine

Access to resources Recommend Favorite

Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation

By Gomy Israel  

Familial Cancer, Vol. 9, Iss. 4, 2010-12 ,pp. : 635-642

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Genetic Analysis of the Von Hippel-Lindau Disease (VHL) Tumour Suppressor Gene in Gonadal Tumours

By Foster K.   Osborne R.J.   Huddart R.A.   Affara N.A.   Ferguson-Smith M.A.   Maher E.R.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2392-2395

Elsevier

Access to resources Recommend Favorite